TQH2722 Injection

TQH2722 · Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for TQH2722 Injection, covering 2025-08-12 to 2026-04-20. Get the full timeline:

Most recent: Clinical Trial Update: To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis [Phase 3]

See pricing